On Medical Grounds
On Medical Grounds
Medavera
Osteomyelitis: Achieving Antibiotic Penetration
28 minutes Posted Sep 15, 2022 at 10:00 am.
Free CME/CE CREDITS (ACCME, ANCC, ACPE)! For credit visit https://www.onmedicalgrounds.com/PremiumContent/Osteomyelitis, view the additional material, click the CME/CE button, and get your certificate.Dr. Adam Bressler is an infectious disease specialist affiliated with Emory Hillandale Hospital and Emory Decatur Hospital. He will be joining us to discuss the role of antibiotic-resistance and other complications in current treatment regimens for osteomyelitis, developments in novel glycopeptide antibiotic treatments for Gram-positive and antibiotic-resistant osteomyelitis, and the multidisciplinary approach to the diagnosis and treatment of osteomyelitis.
CME/CE information
What is osteomyelitis and why is it tough to treat
Role of antibiotic or antimicrobial resistance
Challenges of bone tissue
Role of biofilms in osteomyelitis
First line treatments often fail
New antibiotics showing promise
Need for guidelines for osteomyelitis treatment
Glycopeptide antibiotics
Glycopeptide antibiotic mechanisms
Telavancin Observational Use Registry (TOUR) study
TOUR methods
TOUR results
Infusion centers and pumps
TOUR demographics
Immunocompromised patients and other risk factors
0:00
28:46
Download MP3
Show notes
Free CME/CE CREDITS (ACCME, ANCC, ACPE)! For credit visit https://www.onmedicalgrounds.com/PremiumContent/Osteomyelitis, view the additional material, click the CME/CE button, and get your certificate.Dr. Adam Bressler is an infectious disease specialist affiliated with Emory Hillandale Hospital and Emory Decatur Hospital. He will be joining us to discuss the role of antibiotic-resistance and other complications in current treatment regimens for osteomyelitis, developments in novel glycopeptide antibiotic treatments for Gram-positive and antibiotic-resistant osteomyelitis, and the multidisciplinary approach to the diagnosis and treatment of osteomyelitis. (00:22) CME/CE information(01:57) What is osteomyelitis and why is it tough to treat(02:53) Role of antibiotic or antimicrobial resistance(03:37) Challenges of bone tissue(04:45) Role of biofilms in osteomyelitis(06:30) First line treatments often fail(07:28) New antibiotics showing promise(09:15) Need for guidelines for osteomyelitis treatment(10:35) Glycopeptide antibiotics(11:08) Glycopeptide antibiotic mechanisms(11:55) Telavancin Observational Use Registry (TOUR) study(13:03) TOUR methods(14:04) TOUR results(16:46) Infusion centers and pumps(17:58) TOUR demographics(20:20) Immunocompromised patients and other risk factors(24:18) Multidisciplinary approachVisit us at OnMedicalGrounds.com for more podcasts! You can subscribe through your podcast platform, our website, or follow us on social media for podcast updates and medical news. Some of our podcasts offer FREE CME/CE credits.LinkTreeTwitterLinkedInInstagram